Petros Grivas: Our phase 2 trial of SG+Pembro in platinum-resistant IO-naive 2L setting

Petros Grivas, Clinical Director of Genitourinary Cancers Program, UW Medicine, shared on X/Twitter:

“Excited for our phase 2 trial of SG+Pembro in platinum-resistant IO-naive 2L setting published Journal of Clinical Oncology ORR 41%, CR 20%, mDOR 11mo (primary endpoint met!) supporting ECOG-ACRIN Cancer Research Group 8231 phase 3 trial launching soon!”

Visit the article website.
Source: Petros Grivas/X